The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Sensor-controlled scalp cooling for chemotherapy-induced alopecia: Safety and effectiveness in primary breast cancer patients exposed to anthracyclines and/or taxanes in the neoadjuvant or adjuvant setting.
 
Christian M. Kurbacher
Honoraria - Amgen; Novartis; Onkotrakt; Pfizer; PharmaMar; RIEMSER; Roche; Tesaro
Consulting or Advisory Role - Amgen; Axios; Hilotherm; NewCo Pharma; Novartis; RIEMSER; Roche; Tesaro
Research Funding - AstraZeneca; Axios; Merck Sharp & Dohme; NewCo Pharma; Novartis; Pfizer; PharmaMar; RIEMSER
Travel, Accommodations, Expenses - Amgen; Hexal; Novartis; PharmaMar; Tesaro; Teva
 
Susanne Herz
No Relationships to Disclose
 
A. Tabea Kurbacher
Honoraria - Amgen (I); Novartis (I); Onkotrakt (I); Pfizer (I); PharmaMar (I); RIEMSER (I); Roche (I); Tesaro (I)
Consulting or Advisory Role - Amgen (I); Axios (I); Hilotherm (I); NewCo Pharma (I); Novartis (I); RIEMSER (I); Roche (I); Tesaro (I)
Research Funding - AstraZeneca (I); Axios (I); Merck Sharp & Dohme (I); NewCo Pharma (I); Novartis (I); Pfizer (I); PharmaMar (I); RIEMSER (I)
Travel, Accommodations, Expenses - Amgen (I); Hexal (I); Novartis (I); PharmaMar (I); Tesaro (I); Teva (I)
 
Gabriele Kolberg
No Relationships to Disclose
 
Nele Kettelhoit
No Relationships to Disclose
 
Jutta A. Kurbacher
Honoraria - Amgen (I); Novartis (I); Onkotrakt (I); Pfizer (I); PharmaMar (I); RIEMSER (I); Roche (I); Tesaro (I)
Consulting or Advisory Role - Amgen (I); Axios (I); Hilotherm (I); NewCo Pharma (I); Novartis (I); RIEMSER (I); Roche (I); Tesaro (Inst)
Research Funding - AstraZeneca (I); Axios (I); Merck Sharp & Dohme (I); NewCo Pharma (I); Novartis (I); Pfizer (I); PharmaMar (I); RIEMSER (I)
Travel, Accommodations, Expenses - Amgen (I); Hexal (I); Novartis; PharmaMar; Tesaro (I); Teva